SONOMA PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 4.22% for the 12-month period ending 2026-03-31, per its 10-K filed 2026-06-16.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2026-06-16
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2025-06-30 was 4.38%.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2016-12-31 was 1.86%, a 2.11% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2016-09-30 was 1.49%, a 8.02% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2016-06-30 was 1.40%, a 35.78% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2026 was 4.22%, a 7.66% decline from fiscal 2025.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2025 was 4.57%, a 18.09% increase from fiscal 2024.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2024 was 3.87%, a 1.28% decline from fiscal 2023.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2023 was 3.92%, a 145.00% increase from fiscal 2022.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month |
|---|---|---|---|---|
| 2026-03-31 | 4.22% 10-K · filed 2026-06-16 | |||
| 2025-12-31 | 4.38% 10-Q · filed 2026-02-10 | |||
| 2025-09-30 | 4.38% 10-Q · filed 2025-11-04 | |||
| 2025-06-30 | 4.38% 10-Q · filed 2025-08-07 | |||
| 2025-03-31 | 4.57% 10-K · filed 2026-06-16 | |||
| 2024-03-31 | 3.87% 10-K · filed 2025-06-17 | |||
| 2023-03-31 | 3.92% 10-K · filed 2024-06-17 | |||
| 2022-03-31 | 1.60% 10-K · filed 2023-06-21 | |||
| 2021-03-31 | 0.58% 10-K · filed 2022-07-13 | |||
| 2020-03-31 | 1.70% 10-K · filed 2021-07-14 | |||
| 2019-03-31 | 2.61% 10-K · filed 2020-07-10 | |||
| 2018-03-31 | 2.04% 10-K · filed 2019-07-01 | |||
| 2017-03-31 | 1.91% 10-K · filed 2018-06-26 | |||
| 2016-12-31 | 1.86% 10-Q · filed 2017-02-17 | 1.83% 10-Q · filed 2017-02-17 | ||
| 2016-09-30 | 1.49% 10-Q · filed 2016-11-15 | 1.45% 10-Q · filed 2016-11-15 | ||
| 2016-06-30 | 1.40% 10-Q · filed 2016-08-09 | |||
| 2016-03-31 | 1.63% 10-K · filed 2017-06-28 | |||
| 2015-12-31 | 1.90% 10-Q · filed 2017-02-17 | 1.70% 10-Q · filed 2017-02-17 | ||
| 2015-09-30 | 1.62% 10-Q · filed 2016-11-15 | 1.66% 10-Q · filed 2016-11-15 | ||
| 2015-06-30 | 2.18% 10-Q · filed 2016-08-09 | |||
| 2015-03-31 | 1.70% 10-K · filed 2016-06-21 | |||
| 2014-12-31 | 1.64% 10-Q · filed 2016-02-16 | 1.97% 10-Q · filed 2016-02-16 | ||
| 2014-09-30 | 2.32% 10-Q · filed 2015-11-10 | 1.42% 10-Q · filed 2015-11-10 | ||
| 2014-03-31 | 1.66% 10-K · filed 2015-06-16 | |||
| 2013-12-31 | 1.75% 10-Q · filed 2014-02-14 | 1.44% 10-Q · filed 2014-02-14 | ||
| 2013-09-30 | 1.42% 10-Q · filed 2013-11-19 | 1.42% 10-Q · filed 2013-11-19 | ||
| 2013-03-31 | 0.72% 10-K · filed 2014-06-30 | |||
| 2012-12-31 | 0.62% 10-Q · filed 2014-02-14 | 0.72% 10-Q · filed 2014-02-14 | ||
| 2012-09-30 | 0.73% 10-Q · filed 2013-11-19 | 0.73% 10-Q · filed 2013-11-19 | ||
| 2012-03-31 | 1.27% 10-K · filed 2013-06-25 | |||
| 2011-12-31 | 0.88% 10-Q · filed 2013-02-13 | 1.34% 10-Q · filed 2013-02-13 | ||
| 2011-09-30 | 1.43% 10-Q · filed 2012-11-08 | 1.52% 10-Q · filed 2012-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |